Skip to main content
. 2021 Feb 10;11:614300. doi: 10.3389/fimmu.2020.614300

Table 1.

Advances in modeling colorectal cancer.

Model Application Advantages Disadvantages
2D In vitro • Adhesion
• Gene expression
• Drug screening
• Simple
• Low cost
• High throughput
• Low predictive power
• Lack of native architecture
• Loss of tumor heterogeneity
 Culture plate
 Wound healing • Migration
3D In vitro • Proliferation
• Migration
• Gene expression
• Drug screening
• Retain native tumor geometry
• Cell-cell/ECM interaction
• Tumor heterogeneity
• Avascular
• High cost
• Low scalability
• Low reproducibility
 Organoid/
 Spheroid
 Co-culture • Stromal crosstalk
• Immune crosstalk
In vivo
 Patient-derived xenografts
• Proliferation
• Migration
• Invasion
• Angiogenesis
• Gene expression
• Drug screening
• Tumor heterogeneity • High cost
• Laborious
• Low predictive power
• Immunocompromised
• Limited metastasis
 Humanized mice • Tumor microenvironment
• Tumor heterogeneity
• Immunocompetent
• High cost
• Laborious
• Incomplete immune function
• Engraftment difficulties
 Genetically engineered mice • Tumor microenvironment
• Tumor heterogeneity
• Immunocompetent
• Natural disease progression
• High cost
• Laborious
• Time consuming
Organ-on-a-chip • Proliferation
Migration
• Intravasation
Extravasation
• Invasion
• Angiogenesis
• Stromal crosstalk
• Immune crosstalk
• Gene expression
• Drug screening
• Tumor microenvironment
• Tumor heterogeneity
• Vascular
• Hydrodynamic properties
• Biochemical gradient
• Precise control
• Easy visualization
• Lack of standardization
• High cost
• Laborious
• Low reproducibility